drug regulator directs medical practitioners to prescribe medicines using generic names exclusively

The Drugs Controller General of India issued a directive instructing all medical practitioners to use generic names exclusively when writing prescriptions for patients. The regulatory order aims to curb the practice of prescribing specific brand names, thereby lowering overall out of pocket medical expenses for consumers.

Enforcing generic prescriptions shifts the choice of specific manufacturer variants to the pharmacist and consumer, potentially increasing competition among drug producers. This mandate reinforces existing medical council guidelines and aims to ensure transparency in patient medication management.

Doctors and healthcare institutions must adapt their prescription workflows to comply with the directive, while pharmacies should prepare for changes in patient purchasing patterns.